Geron and TA Therapeutics present new data supporting utility of their small molecule telomerase activator TAT0002
17-May-2006 -
Geron Corporation and TA Therapeutics, Ltd., a joint venture between Geron Corporation and the Biotechnology Research Corporation of Hong Kong (BRC), announced the presentation of studies demonstrating that their small molecule telomerase activator, TAT0002, enhances the anti-viral activity of ...
AIDS
biotechnology
HIV
+6